Overview

Rosuvastatin in African Americans With Cerebrovascular Disease

Status:
Terminated
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
This study will assess the rate at which rosuvastatin will achieve LDL targets in African American patients with previous history of stroke or TIA.
Phase:
Phase 4
Details
Lead Sponsor:
Wayne State University
Treatments:
Rosuvastatin Calcium